FAQ

Frequently Asked Questions.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses like SARS-CoV-2. Monoclonal antibodies attack the virus and reduce its ability to spread through your body.
No. Vaccination remains the most powerful tool against contracting Covid-19, as well as against hospitalization and death from Covid. mAbs is a therapy that helps those who have been exposed or tested positive to Covid-19 .
Yes. Those who are exposed or test positive for COVID-19 despite vaccination are eligible to qualify to receive monoclonal antibody treatment.
Yes, though it is recommended you wait 90 days post-treatment to get vaccinated.
No. Antibodies do not contain any live virus.
mAbs have been authorized by the FDA for emergency use. Any medical infusion or injection may cause side effects, such as brief pain, bleeding, bruising, soreness, swelling, fever, chills, exhaustion, nausea, headache, and possible infection at the infusion site. In rare cases, hypersensitivity and allergic reactions may also occur during or after an antibody infusion. For this reason, trained healthcare staff will monitor you during and after treatment.
Early treatment with mAbs may prevent the disease from worsening and lessen the length of your symptoms. Additionally, it could protect your household from contracting Covid from you.
Monoclonal antibody treatment is at no cost to the patient.
Once you qualify, we’ll reach out to you to schedule treatment. Treatment will be administered by a trained professional in the comfort of your own home. You can also search for a site by going to the U.S. Department of Health and Human Services website, or by calling them at 1-877-332-6585 (for English) or 1-877-366-0310 (for Spanish).
Monoclonal antibody treatment is at no cost to the patient and is billed to insurance or the /federal uninsured fund with no out-of-pocket cost